4Wang QP, Nakai Y. The dorsal raphe: an important nucleus in pain modulation, Brain Res Bull,34(1994) : 575 - 585.
5Montagne-Clavel J, Oliveras JL, Martin G. Singleunit recordings at dorsal raphe nucleus in the awake-anesthetized rat: spontaneous activity and responses to cutaneous innocuous and noxious stimuiations. Pain, 1995, 60 : 303 -310.
6He L, Wang W, Gao M, et al. Expression of c-fos protein in serotonergic neurons of rat. Acupunct-Electrother-res, 1997, 17:243.
7Rodella L, Rezzani R, Gioia M. Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation. Brain Res Bull, 1998, 47 : 357 -366.
8Vincent SR, Kimura H. Histoclaemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 1992,46 : 755 -784.
9Snyder SH, Bredt DS. Nitric oxide as a neuronal messenger. TIPS, 1991,12 : 125 - 128.
10Stegmann JU, Muth-Selbach U, Holthusen H.The significance of nitric oxide in nociception and spinal pain processing. Anasmesiol Intensiwned Notfallmed Schmerzther, 2001, 36:276-281.
4Chen CC, Akopian AN, Sivilotti L,et al. A P2X purinoceptor expressed by a subset of sensory neurons. Nature, 1995,377:428-431.
5Chen Y, Li GW, Wang C, et al. Mechnism underlying enhanced P2X receptor-mediated responses in the neuropathic pain state. Pain, 2005, 119(1-3) :38-48.
6Mestre C, Pelissier T, Fialip J, et al. A method to perform transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods, 1994,32:197- 200.
7Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 1977,4 : 161-174.
8Wheeler-Aceto H, Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology ( Berl), 1991,104 : 35-44.
9McCall WD, Tanner KD, Levine JD. Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett, 1996,208:45-48.
10Neelands TR, Burgard EC, Uchic ME,et al. 2', 3'-O-(2,4,6, trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor. Br J Pharmacol, 2003,140: 202-210.
